On the Link between Ellagic Acid and the Immune Balance between Human Mononuclear and Colon Carcinoma Cells
Received Date: Oct 29, 2017 / Accepted Date: Nov 12, 2017 / Published Date: Nov 19, 2017
Pomegranate and particularly its phenolic compound ellagic acid (EA) have been well renowned as a therapeutic remedy for a long list of illnesses including inflammation and cancer. The beneficial activity of EA has been attributed to a number of factors comprising its immunomodulatory effect. Our aim was to examine the effect of EA on the immune relationship between human peripheral blood mononuclear cells (PBMC) and colon cancer cells from two human colon carcinoma cell lines.
Keywords: Mononuclear cells; Cancer cells; Interleukins; Cross-talk
Citation: Bessler H, Djaldetti M (2017) On the Link Between Ellagic Acid and the Immune Balance Between Human Mononuclear and Colon Carcinoma Cells. Immunol Curr Res 1: 101.
Copyright: © 2017 Bessler H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 1772
- [From(publication date): 0-2017 - Sep 26, 2021]
- Breakdown by view type
- HTML page views: 1548
- PDF downloads: 224